Cargando…

Correction: Zhang et al. Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli. Pharmaceutics 2022, 14, 1804

Detalles Bibliográficos
Autores principales: Zhang, Linlin, Wang, Yuanyuan, Li, Dengjin, Wang, Liang, Li, Zhenzhou, Yan, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610472/
https://www.ncbi.nlm.nih.gov/pubmed/37896278
http://dx.doi.org/10.3390/pharmaceutics15102516
_version_ 1785128263166722048
author Zhang, Linlin
Wang, Yuanyuan
Li, Dengjin
Wang, Liang
Li, Zhenzhou
Yan, Fei
author_facet Zhang, Linlin
Wang, Yuanyuan
Li, Dengjin
Wang, Liang
Li, Zhenzhou
Yan, Fei
author_sort Zhang, Linlin
collection PubMed
description
format Online
Article
Text
id pubmed-10610472
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106104722023-10-28 Correction: Zhang et al. Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli. Pharmaceutics 2022, 14, 1804 Zhang, Linlin Wang, Yuanyuan Li, Dengjin Wang, Liang Li, Zhenzhou Yan, Fei Pharmaceutics Correction MDPI 2023-10-23 /pmc/articles/PMC10610472/ /pubmed/37896278 http://dx.doi.org/10.3390/pharmaceutics15102516 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Zhang, Linlin
Wang, Yuanyuan
Li, Dengjin
Wang, Liang
Li, Zhenzhou
Yan, Fei
Correction: Zhang et al. Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli. Pharmaceutics 2022, 14, 1804
title Correction: Zhang et al. Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli. Pharmaceutics 2022, 14, 1804
title_full Correction: Zhang et al. Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli. Pharmaceutics 2022, 14, 1804
title_fullStr Correction: Zhang et al. Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli. Pharmaceutics 2022, 14, 1804
title_full_unstemmed Correction: Zhang et al. Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli. Pharmaceutics 2022, 14, 1804
title_short Correction: Zhang et al. Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli. Pharmaceutics 2022, 14, 1804
title_sort correction: zhang et al. bimodal imaging of tumors via genetically engineered escherichia coli. pharmaceutics 2022, 14, 1804
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610472/
https://www.ncbi.nlm.nih.gov/pubmed/37896278
http://dx.doi.org/10.3390/pharmaceutics15102516
work_keys_str_mv AT zhanglinlin correctionzhangetalbimodalimagingoftumorsviageneticallyengineeredescherichiacolipharmaceutics2022141804
AT wangyuanyuan correctionzhangetalbimodalimagingoftumorsviageneticallyengineeredescherichiacolipharmaceutics2022141804
AT lidengjin correctionzhangetalbimodalimagingoftumorsviageneticallyengineeredescherichiacolipharmaceutics2022141804
AT wangliang correctionzhangetalbimodalimagingoftumorsviageneticallyengineeredescherichiacolipharmaceutics2022141804
AT lizhenzhou correctionzhangetalbimodalimagingoftumorsviageneticallyengineeredescherichiacolipharmaceutics2022141804
AT yanfei correctionzhangetalbimodalimagingoftumorsviageneticallyengineeredescherichiacolipharmaceutics2022141804